Market Access
pharmaphorum podcast episode 115

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

Market Access
scaling innovation
Sponsored

Scaling innovation across hospitals and nations

Creating healthcare interventions and technological solutions that work is hard enough. But when the goal is sustainable system-wide improvement, it’s the easy part.

Sales & Marketing
Company Profile: 60 Seconds
Sponsored

Company Profile: 60 Seconds

60 Seconds challenges and creates a process which "pulls through" coaching training goals, so that, over time, those involved are measurably improved across a range of skills

Sales & Marketing

Sales & Marketing
Company Profile: 60 Seconds
Sponsored

Company Profile: 60 Seconds

60 Seconds challenges and creates a process which "pulls through" coaching training goals, so that, over time, those involved are measurably improved across a range of skills

Digital

Market Access

Market Access
pharmaphorum podcast episode 115

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D

R&D
Deep Dive: Research and Development 2024

Deep Dive: Research and Development 2024

In this edition of Deep Dive, delve into the revolutionary world of genetic editing as we trace the development of CRISPR, discover why Alexion’s Soraya Bekkali believes now it the time to champion